Publication Date:
2013-04-20
Description:
〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Kaiser, Jocelyn -- New York, N.Y. -- Science. 2013 Apr 19;340(6130):263. doi: 10.1126/science.340.6130.263.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/23599454" target="_blank"〉PubMed〈/a〉
Keywords:
Aged
;
Antineoplastic Agents/*therapeutic use
;
Biomarkers, Pharmacological
;
Biomedical Research
;
Clinical Trials, Phase I as Topic
;
DNA Repair Enzymes/genetics
;
DNA-Binding Proteins/genetics
;
Drug Resistance, Neoplasm
;
Everolimus
;
Female
;
Humans
;
National Cancer Institute (U.S.)
;
Remission Induction
;
Sirolimus/analogs & derivatives/therapeutic use
;
Tumor Suppressor Proteins/genetics
;
United States
;
Urinary Bladder Neoplasms/*drug therapy/*genetics
;
Uterine Neoplasms/*drug therapy/*genetics
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
